ASRT vs SO · rev $125.0M vs P/E 22, rev $29.55B
Assertio Therapeutics Inc (ASRT) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
ASRT currently screens at market cap $151.5M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the ASRT and SO stock pages for the full models.
Not investment advice.